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Background: This project engages patients and physicians in the development of Decision Boxes, short clinical topic
summaries covering medical questions that have no single best answer. Decision Boxes aim to prepare the clinician
to communicate the risks and benefits of the available options to the patient so they can make an informed decision
together.
Methods: Seven researchers (including four practicing family physicians) selected 10 clinical topics relevant to
primary care practice through a Delphi survey. We then developed two one-page prototypes on two of these topics:
prostate cancer screening with the prostate-specific antigen test, and prenatal screening for trisomy 21 with the
serum integrated test. We presented the prototypes to purposeful samples of family physicians distributed in two
focus groups, and patients distributed in four focus groups. We used the User Experience Honeycomb to explore
barriers and facilitators to the communication design used in Decision Boxes. All discussions were transcribed, and
three researchers proceeded to thematic content analysis of the transcriptions. The coding scheme was first
developed from the Honeycomb’s seven themes (valuable, usable, credible, useful, desirable, accessible, and
findable), and included new themes suggested by the data. Prototypes were modified in light of our findings.
Results: Three rounds were necessary for a majority of researchers to select 10 clinical topics. Fifteen physicians and
33 patients participated in the focus groups. Following analyses, three sections were added to the Decision Boxes:
introduction, patient counseling, and references. The information was spread to two pages to try to make the
Decision Boxes less busy and improve users’ first impression. To try to improve credibility, we gave more visibility to
the research institutions involved in development. A statement on the boxes’ purpose and a flow chart representing
the shared decision-making process were added with the intent of clarifying the tool’s purpose. Information
about the risks and benefits according to risk levels was added to the Decision Boxes, to try to ease the adaptation
of the information to individual patients.
Conclusion: Results will guide the development of the eight remaining Decision Boxes. A future study will evaluate
the effect of Decision Boxes on the integration of evidence-based and shared decision making principles in clinical
practice.
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Resources for finding medical evidence have evolved
greatly in the past few years. Searches take less time and
results are more relevant than ever before. For many
clinical questions, however, even the best available evi-
dence does not always produce a single best answer.
In some cases, the scientific evidence about outcomes
is insufficient; in others, proof of benefit is more or less
counter-balanced by proof of harm. In 2007, Clinical
Evidence classified 51% of treatments as having insuffi-
cient evidence and 7% of treatments as tradeoffs between
benefits and harms [1].
Where two or more medically acceptable options exist,
the choice should depend on the patient’s circumstances,
values, and preferences [2]. Values and preferences refer
to patients’ perspectives, beliefs, expectations, and goals
for life and health, and more broadly to the processes
patients use to consider the options and their relative
benefits, harms, costs, and inconveniences [3]. To make
an informed choice, patients thus need access to the best
available information, presented in a format that makes
it easy for them to make a decision consistent with their
values and preferences [4].
Since 1992, the field of shared decision making has
mainly focused on developing and evaluating patient
decision aids: interventions designed to translate infor-
mation more directly to patients and to help them better
clarify their values [5]. Most patient decision aids are
designed so that patients can work through them on
their own. Studies show that printed, electronic, and
audiovisual patient decision aids help increase patients’
knowledge, feeling of being adequately informed, and
participation [5], and reduce the overuse of screening
or treatment options not clearly associated with health
benefits for all [6]. The research also shows, however,
that while patients want information about their medical
condition and treatment, they do not necessarily wish
to be responsible for deciding on treatment [7]. In other
words, patient decision aids can only go so far: patients
want their healthcare provider’s input on their care.
Other than training and continuing medical education
programs for healthcare professionals [8], relatively less
efforts have focused on how to foster a culture where
clinicians embrace shared decision making as a clinical
skill [9].
In this article, we present a tool designed for clinicians
that aims to improve the participation of both patient
and clinician in the decision-making process. This tool,
called the Decision Box, is intended to help the clinician
recognize that a decision needs to be shared with the pa-
tient, prepares the clinician to communicate evidence-
based information to the patient, and assists the clinician
in seeking patient’s values and preferences regarding the
decision to be made. The Decision Box is a short clinicalsummary [10,11] that integrates the best available evi-
dence from studies and syntheses to provide quantitative
information on management options. It is specialized to
cover medical questions that have no single best answer.
More than a summary, though, it is framed in a way to
help the user weigh the risks and benefits of all options
in light of the patient’s individual health status. It also
offers guidance on the shared decision-making process.
Our objective was to develop Decision Box prototypes,
test them with patients and clinicians, and try to improve
them by addressing the barriers identified during user
testing with regards to the communication design. More
specifically, this paper presents the process used to select
clinical topics for 10 Decision Boxes, the evaluation of
users’ experience of the tool, and the pre-test of a ques-
tionnaire that we will use in a future implementation
study.
Methods
This project was approved by the research ethics com-
mittees of the Centre de Recherche du Centre Hospita-
lier Universitaire de Quebec and McGill University.
Selection of clinical topics for the decision boxes
Using a Delphi survey described elsewhere [12], a panel
of seven of the researchers involved in this project
(including four practicing family physicians) selected 10
clinical topics they perceived as relevant to primary
care practice. Because of our interest for the translation
of genetic innovations to the population, we initially
instructed the panelists to select two genomic topics
among the 10, but at the second round we changed our
instructions and asked them to select three instead. The
panel was instructed to select topics that did not have
a single best choice: i.e., the decision addressed should
enclose scientific uncertainty about the outcome or bal-
ance of benefits and harms [5]. Panelists were asked
to propose additional topics after the first round of the
survey. At each round, we retained the topics that were
chosen by all panelists, and removed the topics that were
chosen by three panelists or less. The survey was stopped
after three rounds.
Development of the decision box prototypes
To develop the Decision Box prototypes, we chose two
topics that were more interesting to clinicians (selected
early in the Delphi), that targeted different populations
to maximize the diversity of participating patients, and
that would be easier to explain because patients were
generally familiar with them. We thus chose ‘Prenatal
screening for the detection of trisomy 21’, and then had a
choice between ‘Colorectal cancer screening with fecal
occult blood test’ and ‘Prostate cancer screening with the
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cause of the controversy around this test.
We planned the documents so they would respond to
the learning objectives of the training program (Table 1).
We developed a first version of the Decision Box on PSA
testing, based on the communication design of the Drug
Facts boxes [13] and on research on risk communication
(described in [12]). At this stage, the document consisted
in a simple two-column black and white table with text
and colour graphics. It was presented to the members
of the Canada Research Chair in Implementation of
Shared Decision Making, in Quebec (Canada), who grave
their opinion on the elements that should be removed
and those that should be kept, together with general
comments on the tool. We modified this version and
submitted it to a graphic designer who chose the graph-
ical display. We then produced the second prototype on
prenatal screening directly with the graphic designer.
Presentations of the tools to experts in shared decision
making (SDM), knowledge translation, and genomics at
scientific meetings led to four more versions before the
design proved satisfactory.
Each prototype was written in both French and
English, and divided into three sections (Figures 1 and 2).
At the top, the ‘Presentation of the intervention to
patients’ section described the intervention for which a
decision was required, in straightforward lay language.
This section broadly described the accuracy of the test,Table 1 Specifications for the decision box independent
learning program
General objective: To use shared decision-making principles to involve
patients in the decisions regarding each of the clinical questions
covered.
Specific learning objectives Instructional activities
• To describe the available options
for each clinical question;
• Reception of a series of Decision
boxes, at regular intervals, by
email;
• To describe the specificity and
sensitivity of the test (only for
screening procedures);
• To describe the probabilities of
risks and benefits of the available
options for each clinical question;
• Reading of the Decision boxes;
• Assessment of each Decision box
using a web-questionnaire;
• To revise the pros and cons of
each of the available option for
each clinical decision;
• Reading of the additional
resources on patient counselling
provided on the website;
• To judge the quality of the best
available data for each clinical
decision;
• Viewing the tutorial on the
Internet;
• To list the questions to identify
patients’ decision making needs;
• Using the information provided
in the Decision box in practice
when there is an opportunity.
• To list additional resources
available to patients to address
their decision making needs.the population for which intervention might be appro-
priate, and clarified the decision to be made. The ‘Study
Findings’ section presented the results of a single study
that we considered to be the most relevant to present
population or ‘average risks’ of benefits and harms of the
intervention and to have the highest strength of evidence.
This section first described the study (the study popula-
tion and the length of follow-up) in a single sentence and
then combined narration, graphics, and numbers to out-
line the study’s findings about the intervention’s benefits
and harms. We used a few additional studies to present
important elements that were not covered by the main
study, for example, the proportion of miscarriages fol-
lowing amniocentesis, but to simplify the document we
did not describe the studies themselves, and we did not
give references to these studies. At the bottom, a ‘Con-
fidence In The Results’ section gave publication informa-
tion about the main study on which the ‘Study Findings’
section was based and made a statement about the study’s
quality and its consistency with other published studies
on the same topic. This assessment was adapted from
the methodology of the Grading of Recommendations
Assessment, Development and Evaluation (GRADE)
Working Group [14].
A graphic designer produced the prototypes as one-
page color documents. The main title of each prototype
was ‘Decision Box’; the subtitle stated the intervention.
The endorsement of each prototype by Laval University
and the date of the last update were placed in small let-
ters at the bottom.
Users’ experience of the decision box prototypes
Participant inclusion criteria and the recruitment process
To explore users’ perceptions of the communication
design used in the prototypes and to seek suggestions for
improvement, we conducted two focus groups with fam-
ily physicians and four focus groups with patients. Using
their professional networks, two members of the research
team (ML and RG) recruited practicing family physicians
from the Family Medicine Units in Quebec and Montreal
in Canada. Patients were recruited from these two sites
and met criteria for participation if they were: men
between 45 and 75 years old, or women between 20 and
40 years old who wanted to have a child, were pregnant,
or were already mothers. Participants received a monet-
ary compensation for their participation. The clinics’ sup-
port staff distributed information sheets about the study
to eligible patients. Interested patients then contacted
the research team to participate.
Focus groups
We presented the two Decision Box prototypes to
two groups of family physicians: first, a French-speaking
group and second, an English-speaking group. We
Figure 1 The Decision Box prototype on prenatal screening for trisomy 21 (BEFORE evaluation).
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Figure 2 The Decision Box prototypes on prostate cancer screening (BEFORE evaluation).
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of patients who agreed to participate and who qualified
for the study (in other words, we presented the proto-
type on prostate cancer screening to male volunteers and
the prototype on prenatal screening to female volunteers).
We used a maximum variation strategy to populate the
samples, which we segregated by mother tongue. In this
way, we constituted four focus groups of patients: French-
speaking men, French-speaking women, English-speaking
men, and English-speaking women.
We conducted all interviews at the clinics where par-
ticipants were recruited. We used a semi-structured
interview guide to explore participants’ experience of
the communication design used in Decision Boxes based
on Peter Morville’s User Experience Honeycomb [15].
More precisely, physician interviews explored the tool’s
value in preparing them to communicate scientific infor-
mation to patients and helping patients make informed,
value-based decisions. The patient interviews explored
how patients felt about their physician reading the
Decision Box before their clinical encounter to better
prepare for their visit, and to ask them whether the Box
contained all the information they needed to make a
decision.
The focus groups were moderated by two experienced
interviewers: one for the French-speaking groups and
one for the English-speaking groups. One moderator
held a master’s degree in anthropology and the other a
master’s degree in library and information science. Both
were research professionals at the time of the study. Two
observers (AG and either PP, ML or RG) took notes on
the process and content of the discussions. One observer
(AG) was a postdoctoral fellow, one was a researcher
(PP), and the others (RG and ML) were family physicians
and colleagues of the participating physicians. No phys-
ician was present during interviews of one of his/her
own patients. One observer (AG) was present at all
focus group discussions, to ensure consistency in the
approach. All discussions were audiotaped and profes-
sionally transcribed.
Questionnaires
At the beginning of each focus group, we collected
demographic data from all of the participants and ques-
tioned them about their health history regarding the
topic addressed in the Decision Box. After the focus
group, the patients were administered the Decisional
Conflict Scale [16]. Following the focus groups, family
physicians pre-tested a self-administered questionnaire
to be used in a larger study on the implementation of the
Decision Boxes (Additional file 1). This questionnaire
evaluated the respondents’ perceptions of the Decision
Box on PSA testing for prostate cancer screening. The
questionnaire measured physicians’ interest in theclinical topic using a visual analog scale that ranged from
0 (no interest) to 10 (deep interest). It also comprised the
information sub-scale of the Decisional Conflict Scale
[16], the Information Assessment Method [17], a scale
based on the Theory of Planned Behaviour that evaluated
physicians’ intention to use in their practice what they
had learned from the Decision Box to help their patients
make an informed decision [18], and a scale based on the
Technology Acceptance Model (TAM2) that evaluated
physicians’ perceptions of the usefulness and ease of use
of the Decision Box [19].
Analysis
One researcher (AG) and two research professionals per-
formed a thematic qualitative data analysis of the content
of focus group discussions following a hybrid deductive/
inductive approach [20]. This analysis identified barriers
and facilitators to the participants’ experience with the
prototypes. The deductive analysis searched for attributes
related to the seven facets of the User Experience Honey-
comb [15]: valuable, usable, credible, useful, desirable, ac-
cessible, and findable. The inductive analysis integrated
new themes mentioned by participants. First, to assess
whether the User Experience Honeycomb applied and to
explore possible sub-themes, the researcher and the two
research professionals separately went through the same
portion of one of the focus group transcripts and noted
any attributes related to the Honeycomb. The three
coders then compared their results and came to a con-
sensus on the themes and sub-themes mentioned in this
transcript sample. Next, they noted these themes and
sub-themes in a manual of codes, labelling and defining
them as well. The transcripts were entered as project
documents into specialized software (NVivo 9, QSR Inter-
national, Cambridge, MA, USA), and the codes developed
for the manual were entered as nodes. One research
professional then applied these codes to the English
interviews while the other applied them to the French
interviews to identify meaningful units of text. The first
author (AG) then read all transcripts and reviewed the
codes applied by the research professionals to the six
interviews to ensure completeness and appropriateness
of the code manual, and consistency of approach. Again,
any modifications to the predetermined code manual
were discussed among the three coders until consensus
was reached.
We modified the Decision Boxes to take into account
users’ comments. We also performed descriptive statis-
tical analyses of the answers to the questionnaire.
Results
Selection of clinical topics
For genomic topics, two rounds were necessary for a
majority of panelists to select the same three clinical
Table 2 Clinical topics and number of panelists selecting each topic at each survey round (*: indicates the round at
which the topic was selected)
a) Genomic topics No of panelists
Round 1 Round 2
• Screening for BRCA1 or BRCA2 gene mutations to evaluate the risk of breast and ovarian cancer 5 7*
• Newborn screening for sickle cell anemiaa 0 -
• Newborn screening for MCAD (medium chain acyl-CoA dehydrogenase) deficiency 0 -
• Hereditary colorectal cancer screening in individuals with high risks of colorectal and endometrial cancers 1 4*
• Screening for hereditary hemochromatosis in patients with abnormal ferritin level or abnormal
transferrin saturation or in patients with family members with hemochromatosis
0 -
• Prenatal screening for the detection of Down’s syndrome, Trisomy 18, and open neural tube defects 5 7*
• Genotype testing for patients initiating warfarin treatment 1 3
• Screening for hypertrophic cardiomyopathy (HCM) in individuals with clinical features or a family history of HCM 0 -
• Testing for CDKN2A and CDK4 gene mutations to evaluate the risk of melanoma and the predisposition for
pancreatic cancer
1 0
• Genetic testing for factor V Leiden to identify those at an increased risk for venous thromboembolism (VTE). 0 -
Additional topics proposed by the panelists at first round
• Screening for hereditary prostate cancer - -
• Screening for MEN predisposing mutations - 0
b) Other topics No of panelists
Round 1 Round 2 Round 3
• Colorectal cancer screening with faecal occult blood test 7* - -
• Prostate cancer screening with the prostate-specific antigen (PSA) test 7* - -
• Abdominal aortic aneurysm screening with abdominal ultrasound 1 - -
• Treatment of mild to moderate depression with selective serotonin reuptake inhibitors (SSRIs) or St. John’s wort 2 - -
• Treatment of Alzheimer’s disease with cholinesterase inhibitors 5 4 5*
• Antibiotic treatment for patients with exacerbated chronic obstructive pulmonary disease (COPD) 4 4 4
• Intensive glycemic control in type 2 diabetes 4 4 5*
• Prevention of strokes with antithrombotic therapy in patients with atrial fibrillation 3 - -
• Prevention of cardiovascular events with antihypertensive drug in patients over 60 years old presenting with
essential hypertension
4 2 -
• Prevention of vascular diseases with acetylsalicylic acid (ASA) 6 6 7*
• Prevention of osteoporotic fractures with bisphosphonates (alendronate, risedronate, etidronate) in postmenopausal
women
6 4 7*
• Primary prevention of cardiovascular disease with statins in persons with cardiovascular risk factors 5 4 7*
• Prevention of cervical cancer with the vaccine against the human papillomavirus (HPV) 3 - -
Additional topics proposed by the panelists at first round
• Antibiotics versus nasal steroids for the treatment of acute sinusitis in adults - 1 -
• Early palliative care for patients with metastatic non–small-cell lung cancer - 1 -
• Omega-3 for mild to moderate depression - 1 -
• Delayed versus immediate antibiotic prescriptions for acute uncomplicated urinary tract infection in women - 0 -
• Prevention of prostate cancer with 5 alpha-reductase inhibitors (finasteride and dutasteride) - 2 -
• Breast cancer screening for women age 40 to 50 with no risk factors - 1 -
• Prevention of breast cancer with tamoxifen - 2 -
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Table 3 Characteristics of participating patients in each focus group
Women Men
French English French English
n 9 8 9 7
Median age (min : max) 30 (20 : 38) 30 (24 : 38) 54 (46 : 62) 51 (47 : 66)
Employment status (n)
Employed full-time 6 6 3 5
Employed part-time 0 1 1 2
Unemployed and seeking employment 0 1 1 0
Unemployed and not seeking employment 0 0 0 0
Retired 0 0 3 0
Other 3* 0 1∀ 0
Highest education level (n)∴
No high school 0 0 0 0
Some high school - did not graduate 0 0 0 1
High school degree or certificate of equivalency 0 0 3 0
Some college – did not graduate 0 0 0 0
College degree 2 1 1 2
Some university – did not graduate 1 1 5 0
University degree 6 6 0 3
* 1 preventive withdrawal because of pregnancy and 2 students.
∀ absence from work as a result of sickness.
One response is missing in the English-speaking men’s group.
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was achieved after the third round. In round one, one
panelist selected a single genomic topic instead of two as
instructed, and nine of the other topics instead of eight.
At the second round, one panelist selected six topics
instead of the five as instructed. Only prostate cancer
screening and colorectal cancer screening with the fecal
occult blood test were unanimously selected during the
first round of the survey.Users’ experience of the decision Box prototypes
Participants’ characteristics
Eighteen of 35 (51%) eligible physicians agreed to parti-
cipate, and 15 attended the interviews—all participants
stayed until the end. All physicians who did not agree to
participate stated they were not free on the date of the
focus group. Seven physicians participated in the French
group interview and eight in the English interview; 73%
were women. Most were between 30 and 60 years old
(median = 40 years old) and had practiced medicine for
5 to 37 years (median = 13 years). The four groups
of patients totalled 33 participants. Within groups of
women and groups of men, levels of education, employ-
ment status, and age were similar, regardless of language;
but these characteristics differed between groups of men
and women (Table 3).Among the 17 women participants, 10 had been preg-
nant at least once and none had a child with trisomy 21.
Seven went through prenatal testing for trisomy 21, and
none received a positive result. One had an amniocen-
tesis, and her fetus was not diagnosed with trisomy 21.
Of the participating women, 10 had received informa-
tion on prenatal screening before the interview and men-
tioned several sources of information (sometimes more
than one source): eight mentioned their doctor, their
medical clinic or the hospital; three mentioned the inter-
net; and some mentioned a university course, a specia-
lised prenatal private clinic, friends and family, and
books. Of the 16 men who participated, nine had been
screened for prostate cancer at least once, four had
received a positive result following screening, and three
had had a biopsy. In two of the three, the biopsy had
revealed prostate cancer, for which they were treated.
Eight of the male participants had received information
on prostate cancer screening before the interview. As
sources of information on the cancer, seven mentioned
their doctor, their medical clinic, or the hospital, two
mentioned an advertisement or the television, one med-
ical publications, and one family members.
Focus groups
The focus groups with physicians lasted about one hour






























Transmitting the document to one’s peers
(desirable, credible, valuable)
Integrating the information Using the information in practice
Figure 3 Steps of the users’ experience of an evidence-based shared decision-making support tool over time. Correspondence between
each step and facets of the model used to develop the interview guide (i.e., Morville’s User Experience Honeycomb) are shown in parenthesis.
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Decision Boxes mostly concurred, although the phys-
icians discussed more the data, whereas patients dis-
cussed more the shared decision-making process.
The User Experience Honeycomb used to develop the
interview guide describes seven facets (or qualities) of an
individual’s experience of a product. During coding, we
felt that the user’s experience of a Decision Box would be
best represented as a process, because the facets at play
change from the time when clinicians access the Decision
Box to the time when they use it in their practice. Follow-
ing our analysis, we propose eight successive steps to
users’ experience of an evidence-based shared decision-
making support tool over time, and we describe which
facets of the users’ experience are at play at each of these
steps (Figure 3). The eight proposed steps are successive:
for the document to accomplish its purpose (here, to assist
the physician to share a decision with the patient), the user
must go through each step in sequence, one after the other.
When analyzing the interviews, we coded barriers and
facilitators to users’ experience of Decision Boxes at each
step. These results are detailed in the Table 3a to 3g, and
we can draw a few more general observations.
Accessing the information
Multiple communication channels were proposed by par-
ticipants to facilitate access to Decision Boxes. Even if we
specified to participants that Decision Boxes were devel-
oped to be used primarily before the clinical encounter,
some still proposed to use them during the clinical
encounter and suggested that printed format or mobile
applications might then be more useful than the Internet.
Integrating the information
Most of the interviews’ discussions concerned the value
of the communication design to integrating the informa-
tion. Understandability, the format of graphics and miss-
ing information were the factors most often reported asbarriers to the ‘Finding and understanding the informa-
tion’ step (Table 4, section c). Comments on the under-
standability of the information mostly referred to how
the presentation of the information allowed the user
to pinpoint the risks or the benefits of the presented
options. Participants generally found the proposed bar
charts to be complex, and many suggested not using any,
or using alternate representations such as flow charts or
little men (icon array). Among the data found to be miss-
ing by participants, they reported that alternative screen-
ing tests should be described. Concerning the format of
numbers, one-half the groups mentioned that presenting
percentages would be helpful. Some barriers to trusting
the information were more often reported for the pros-
tate cancer prototype, namely subjectivity and informa-
tion differing from what participants already knows.Using the information in practice
Concerning the tool’s usefulness in the clinical setting,
there was a general perception that synthesized and
simplified information facilitated the communication
of information to patients (Table 4, section e). Yet, five
groups reported difficulty applying the information to
individual patients as a barrier to communicating the
information. There was general agreement that a lack of
non-scientific information was a barrier of the Decision
Box to seek patient values (Table 4, section f ) and that
guidance to make a decision was lacking. Specific aspects
of the clinical topics covered in the prototypes (PSA or
prenatal testing) were reported to influence the sharing
of decisions with patients. For the PSA test, the lack of
evidence on which to base a decision and risks’ out-
weighing benefits were perceived as barriers to sharing
the decision with patients (Table 4, section g). Having
appreciated using the Decision Box was most often
reported by physicians as a facilitator to sharing of the
Decision Box with peers.
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Following analyses, we modified the Decision Box proto-
types to try to take the participants’ perceptions and sug-
gestions into account (Figures 4 and 5). Redesigning
of the prototypes emerge mostly from the analyses, as
many solutions were found during the analysis phase, by
discussion among the three coders. Potential solutions to
the identified barriers were discussed again with the pro-
fessionals and researchers of the Canada Research Chair
in Implementation of Shared Decision Making. Redesign-
ing of the graphic aspects was generally straightforward:
the first author (AG) used the graphic design software
herself, and integrated modifications to the prototypes as
ideas were emerging. The graphic designer was involved
more punctually to help resolve specific issues (for ex-
ample, with the graphic on the Decision box on prenatal
screening).
We first added three sections: an introduction-to-the-
document section, a patient counseling section, and a
reference section. The document was spread over two
pages to make it look less busy and to try to improve first
impressions. To try to improve the boxes’ credibility, we
made more visible the names of the research institutions
involved in developing the boxes. A statement on the
boxes’ purpose and a flow chart representing the shared
decision making process were added to clarify the
Decision Box’s purpose. Where there was evidence, the
presentation of risk factors and of benefits and harms of
the intervention according to these factors became essen-
tial elements of the modified documents, because we
thought that this would help physicians apply and com-
municate the information to individual patients. In the
patient counseling section, we proposed three questions
that physicians could ask patients to help clarify patients’
values and preferences and to guide the decision-making
process. Last, hoping to clarify that the Decision boxes
are based on the best available evidence, we added more
references to studies and, when applicable, described the
design used by the studies, the study participants, and
the length of the intervention.
Patients’ decisional conflict after the interview
After the interview, the patients’ mean Decisional Con-
flict Scale score was 25% (±SD 12%) and ranged from 2%
to 44%, indicating low decisional conflict.
Questionnaire for family physicians
Physicians’ mean interest in PSA testing for prostate
cancer screening as a clinical topic was 7.9 ± 1.2 (SD)
on a visual analog scale ranging from 0 (no interest) to
10 (deep interest). On the information subscale of the
Decisional Conflict Scale, which ranged from 0 (feels ex-
tremely informed) to 100 (feels extremely uninformed),
physicians gave a mean score of 25.6% ± 10.7 for theDecision Box on PSA testing for prostate cancer, indicat-
ing that they felt well-informed after reading it. Using the
Information Assessment Method, all participants
reported that the Decision Box on PSA testing had an
impact on them or their practice. The most frequently
reported type of cognitive impact was that it would re-
mind them of something they already knew (93%). All
physicians reported they would use this information for
their patients, and the most frequently reported planned
use was to resolve a doubt (60% of physicians). Eighty-
seven percent of physicians expected the information to
benefit their patients, with the most frequently reported
expectation being that the information would make the
patient more knowledgeable about health or healthcare
(60%). Physicians’ intention to use in their practice what
they learned from the document to help their patients
make an informed decision averaged 5.4 ± 1.2 (SD) on a
scale from 1 (strongly disagree) to 7 (strongly agree), in-
dicating that they had the intention to use what they
learned. On average, physicians perceived the Decision
Box prototypes as being somewhat easy to use (4.2 ± 1.5)
and useful (4.8 ± 1.0) on a scale ranging from 1 (strongly
disagree) to 7 (strongly agree).
Discussion
In this study, we explored facilitators and barriers to the
communication design of two Decision Box prototypes
by engaging users in their testing, and we modified these
prototypes to try to minimize the influence of the
observed barriers. Our findings improve understanding
of the design of evidence-based shared decision-making
support tools, which in turn will improve their value for
end users.
Accessing the documents
With 95% of Canadian physicians using electronic tools
[21], the Internet might be the most efficient commu-
nication channel to deliver Decision Boxes to clinicians.
However, participants suggested accessing Decision Boxes
through multiple channels, such as printed documents,
the internet, and mobile applications, especially for use
during the clinical encounter. A website offering a one-
click access to printable Decision Boxes may thus be use-
ful in clinical encounters.
Integrating the information
Newer information tools summarizing the current best
evidence, such as Decision Boxes and synopses, respond
to the widely acknowledged problem of information over-
load in healthcare. Brevity and lower density of information
are especially critical to foster a positive first impression
of such tools [22,23], and to improve users’ comprehen-
sion of the options [24]. Other factors are also at play
during the first contact between the receiver and the
Table 4 Factors related to users’ experience of the Decision Box and frequency of interviews where they were
mentioned (Men = participant from the men’s group; Wo = participant from the women’s group, MD = participant
from the physicians’ group; FR = French-speaking group; En = English-speaking group)





a) Accessing the Decision Box *
- As printed document/not as printed
document
It has some important information that I could just have handy instead of
looking on the Internet at that moment. (MD-En)
2 2
- In an electronic format You can use something electronic if you’re sitting in front of a computer and
you show your patient the screen. (MD-En)
2
- As mobile version Now that it exists as application for our pocket computers, we do not carry
this with us all around. (MD-Fr)
2
- Multi-channel distribution I actually like having something physical, especially if it’s going to be used to
counsel patients. I like an Internet link to educate myself. (MD-En)
1
b) Having a positive first impression
Appropriate/inappropriate titles I was expecting pros, cons. This is kind of what I went through with the
pregnancy with Cedric. I had to go through understanding the pros and the
cons and debating whether I wanted to do it or not. (Wo-En)
3 3
Credibility/lack of credibility it’s going to have more credibility when they know that there is no drug
company. (MD-En)
3 1
Too much text or too many numbers, too
dense
Too busy, too busy. (MD-En) 3
Sound, explicit methodology It needs to come from an organization that can say, “Look, we did the
research, and this is what we know in 2011. We will update the box in 2013 at
the latest.” (MD-Fr)
3
Simplicity - length It’s like a cheat sheet. On a cheat sheet, you would squeeze everything, every
tiny little drop that you could. This is a cheat sheet and it’s all in one page. I’m
happy. (MD-En)
3
Good color choice I think, color wise, it works fine because there is nothing that is offensive here.
You don’t have a lot of red which may be more scary than other colors so,
color wise I think it works well. (Men-En)
3
Including/not including an introduction It has a good presentation section that says [to the physician], this document
is about this and that, and after it’s described to you, then you will “get it”
(. . .) It is not like having it on my desk without preparation. (MD-Fr)
2 2
Information differs from participants’ prior
knowledge
At present, so many patients are screened. Why. . .what’s the story, why are
specialists proposing such things, you know. How did we get to this point?
(MD-En)
2
Time contraints I thought it was going to be, like, an algorithm, that I can follow. And this is
not. I would not have time to read it for sure.(MD-En)
1
c) Finding and understanding the information in the Decision Box
Information understandable/not
understandable
I think it’s clear. I mean, it gives you. . . it makes a statement. And then, it
shows. . . it gives you the explanation of that statement. And if you read both
of them, you realize that first statement is just being explained on this right




When I first looked at it, I said: “Oh, the graphics are quite. . . not complicated
but there’s lots of stuff on it”. (MD-En)
3 6
Missing information We are often doing the rectal touch together with PSA testing. . .They only





If you say your chance is .5%, well that sounds a lot better than saying, you
know, 5 out of a thousand. (MD-En)
3 5
Good source of information Could it be a good sheet for physicians that do not see pregnancies often, for
residents? I think that yes. In these cases, there is interesting information, really
substantiated.
5
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Table 4 Factors related to users’ experience of the Decision Box and frequency of interviews where they were
mentioned (Men = participant from the men’s group; Wo = participant from the women’s group, MD = participant
from the physicians’ group; FR = French-speaking group; En = English-speaking group) (Continued)
Develops critical thinking Patients, too, learn that medicine is not perfect. We are in a high-technology
era; everybody thinks that we can do anything, that we can know everything.
It’s a widespread idea. This makes it possible to set the record straight for us
and for patients. (MD-Fr)
4
Allows conceptualization It helps us conceptualize. (MD-Fr) 4
Inappropriate language or style The second sentence, what is the test for, it allows the patient to decide to
end the pregnancy. It’s written negatively. It should be either to continue or
to end the pregnancy. (Wo-En)
4
Data presented but not found Talking about age, it says here that the risk of trisomy increases with age of
the pregnant woman. It would be good to know by how much. (Wo-En)
4
Information too basic When I first saw this, it seemed to me that every doctor should know this
already. By heart, without even consulting it. In all honesty, it seems to me the
information here is pretty basic. (Wo-En)
3
Bold important words and use more bullets The other thing I would say is that, again, for the bottom part, the benefits of
screening and the harms of screening, as for the previous, I think it would be
more useful to have it a little bit more [text] bulleted and bold. (MD-En)
2
Appropriate to have both words and
graphics
It’s good that there is a graphic side and a text side, even if in one way, the
same information is found in both places. There is information for people who
learn best when they see something and information for those who like to
read. (Wo-Fr)
1
Objectivity/subjectivity Somebody has a preconceived notion, who wrote this, that you should not,
that it’s not a good idea to go through the screening. And they framed it in
that way. (Men-En)
4 3
Confidence in results section improves
credibility/undermines credibility
It says it’s a moderate, single study of moderate quality. So, you know, it’s not
the best. (Men-En)
1 4
References not detailed enough Is this study a knowledge synthesis, meaning that they took information from
everywhere and synthesized it? Or is it a single study? (. . .) If they verified in
3-4 types of study sites, for me that counts more than a study that was
performed in a single location. (Wo-Fr)
4
Information differs from what participant
already knows
I am glad to know this side of the story, but I’d like to see the other side.
Cancer prevention associations state that screening saves lives, but I don’t
remember seeing any numbers. (MD-Fr)
4
Typos or mistakes Optimistic results, I’ve never heard that expression. So, I was sort of already
thrown off. I didn’t even get to “I like this part.” (MD-En)
3
Scientific quality of the tool It is really important to have up-to-date results. (Wo-Fr) 3
e) Communicating the information to the
patient
Synthesized and simplified information It’s obvious that it can give doctors the words they need to explain things
more simply to their patients. (Men-Fr)
6
Easy/difficult to apply to individual patients I’m 38 now. Can my doctor sit me down in 5 years and use these results to
tell me, no, you don’t need to do a test, or yes, you need to do a test? I mean,




It’s nice how they’ve divided it. The top kind of allows them to position where
their individual patient is in terms of where they are at, where their symptoms
are and then the bottom section gives the broader scope of the research.
(Wo-En)
4 4
Time required to use Decision Boxes would
decrease with familiarity/time constraints
When the physician’s in his office, at the speed he sees me, I am not sure he’d
start explaining this. (Men-Fr)
2 2
f) Seeking the patient’s values
Lack of non-scientific information On one hand, I like that it is neutral and factual, but at the same time, I wish
there were a way to make it more human, to suggest reflection. (Wo-Fr)
5
Would be good to generate discussion If I think it can help me discuss things with a patient. You know, if it can help
having more arguments or easier language or other, new knowledge, I would
keep it. (MD-En)
2
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Table 4 Factors related to users’ experience of the Decision Box and frequency of interviews where they were
mentioned (Men = participant from the men’s group; Wo = participant from the women’s group, MD = participant
from the physicians’ group; FR = French-speaking group; En = English-speaking group) (Continued)
Only scientific information is needed I don’t think your doctor should question your values or your moral beliefs or
your religion. It should be scientifically based. It shouldn’t open up that door.
It’s personal. (Wo-En)
2
Doctor’s lack of communication skills Even if everything is written as completely as it is here, [even if] the doctor
has all the data, he can still come along and bang! be a real drip and say,
“Here we go, here we go, now just go on home and think about it. Come
back when you’re ready to tell me what you’ve decided.” (Wo-Fr)
2
Too complicated to be discussed with the
patient
For me, in the harms [section], it makes a little more sense to have of the
1000 men screened pros and cons but not necessarily the other number. To
have the “not screened” [number] makes the discussion much more complex.
(MD-En)
2
g) Finding and understanding the
information in the Decision Box
Lack of non-scientific information On one hand, I like that it is neutral and factual, but at the same time, I wish
there were a way to make it more human, to suggest reflection. (Wo-Fr)
5
Would be good to generate discussion If I think it can help me discuss things with a patient. You know, if it can help
having more arguments or easier language or other, new knowledge, I would
keep it. (MD-En)
2
Only scientific information is needed I don’t think your doctor should question your values or your moral beliefs or
your religion. It should be scientifically based. It shouldn’t open up that door.
It’s personal. (Wo-En)
2
Doctor’s lack of communication skills Even if everything is written as completely as it is here, [even if] the doctor
has all the data, he can still come along and bang! be a real drip and say,
“Here we go, here we go, now just go on home and think about it. Come
back when you’re ready to tell me what you’ve decided.” (Wo-Fr)
2
Too complicated to be discussed with the
patient
For me, in the harms [section], it makes a little more sense to have of the
1000 men screened pros and cons but not necessarily the other number. To
have the “not screened” [number] makes the discussion much more complex.
(MD-En)
2
h) Trusting the information
Having appreciated using it When we discuss something among colleagues and I say: “Look, I used this in
this way and it really helped me”. If I don’t use it, there’s not much chance
that I will share it with my colleagues. (MD-Fr)
4
Simplicity of the tool – length/Inappropriate
size – too large
It’s simple. Like, I’m not going to hand them 15 pages. (MD-En) 1 1
Good source of new information The fact that you said that it’s the best evidence we have, I find that
interesting. (MD-En)
1
Credibility of the source Because if you guys were sending me this, a box of these, then I would say:
“Oh look the College is endorsing me to use these Decision Boxes.” Well, o.k.
I’m more likely to give them to a colleague. (MD-En)
1
Clinically-based information . . . But the idea that it’s clinically based. . .You give more credit to something
like that. And you get more people to read it. (MD-En)
1
Clear concept –easy to understand If the concept is clear enough. If it is easy to understand. (MD-Fr) 1
Difficult to apply to individual patients I am used to talking about the triple-test. The only value added of a sheet is
to cite numbers that I don’t keep in the top of my mind. People want to
know their risk at 35 years old, their risk of this and that. I can’t apply this as it
is. (MD-Fr)
1
*Only the 2 physician groups discussed this step.
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tion (expertise, trustworthiness) [25]. By clearly identify-
ing three universities as the sources of Decision Boxes in
the modified documents, we are building on the ‘reputed
credibility’ that universities generally possess and on the
‘experienced credibility’ stemming from users’ academicexperiences [26]. Participants also reported that know-
ledge of the tool development methodology would influ-
ence their first impressions of the Decision Boxes.
Consequently, the website hosting the Decision Boxes
will include a methodology subsection to describe the
typical indicators needed to appraise clinical summaries,
Figure 4 Decision Boxes on prenatal screening for trisomy 21 modified to reflect user experience testing (AFTER evaluation).
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ture, and to critically appraise the retrieved sources [10].
Our findings support another study that also reported
understandability of the information as key factor of a
positive user experience [27]. According to Rosenbaum
[28], ‘understandability’ involves two separate dimen-
sions: the users’ perception of their own understanding,
which we explored in this study, as well as an objective
measure of correct understanding that would need to be
tested separately. Hoping to improve users’ perceptions
of understandability, we modified the Decision Boxes to
use percentages to convey probabilities whenever pos-
sible. Major organizations, such as the Cochrane Collab-
oration [29] and the International Patient Decision Aid
Standards (IPDAS) Collaboration [30], have been recom-
mending natural frequencies to present absolute risks.
A recent randomized trial however compared adults’
understanding of five different numerical formats, and
found the percent format had slightly higher comprehen-
sion overall [31]. Following participants’ comments on
the understandability of the graphics used in the proto-
types, we either removed them or simplified them, but
we kept bar graphs because these have been reported to
be readily understood and helpful [32]. The researchliterature is not clear on which graphs are most effective
to communicate health risk [33,34].
Message attributes can also influence credibility [25],
but at a later step that we named ‘Trusting the Informa-
tion’. Participants reported objectivity and confidence in
results as key message attributes that influenced their
trust in the information. To foster perceptions of object-
ivity, negative and positive features of options should be
presented equally to patients [30]. Objectivity might have
been questioned more for the prostate cancer prototype,
first because the size of the harms section was larger than
that of the benefits, but also because its content differed
from what most participants already knew. The theory of
cognitive consistency proposes that information which is
compatible with existing beliefs is the most likely to be
accepted, and that which emphasizes the undesirable
qualities of existing beliefs may be selectively avoided or
ignored [35]. Comments on the ‘Confidence in Results’
section reveal that participants’ trust in Decision Boxes
was influenced by the quality of evidence presented
within. This supports findings from a study of the Cochrane
Collaboration’s summary of findings table in which users
also indicated that the table’s credibility was reduced when
GRADE ratings were low [27,28].
Figure 5 Decision Boxes on prostate cancer screening modified to reflect user experience testing (AFTER evaluation).
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Following participants’ comments, we added information
on the benefits and harms of the intervention according
to individual patient risk, when available, to try to
improve applicability of the Decision Boxes to practice.
Risks can be personalized based on individual risk factors
for a condition (such as age or family history), or it can
be calculated using formulae derived from epidemio-
logical data [36]. A review on the effectiveness of perso-
nalized risk communication in the context of screening
showed little impact of this strategy to promote informed
decision making [36], but another study reported primary
care practitioners preferred personalized risks [37].
Participants mentioned the prototypes lacked non-
scientific information, and this concurs with recommen-
dations to base decisions not only on scientific evidence
but also on patients’ values and preferences when two or
more medically acceptable options exist [2]. To try to
help patients clarify and express their preferences and
values, the modified Decision Boxes proposed three
questions for the clinician to ask patients. Participants
also requested some guidance on the process of shared
decision making and we are planning to provide such
guidance in a tutorial on the website hosting Decision
Boxes. The IPDAS Collaboration suggests that patientdecision aids should provide a step-by-step method to
make a decision or include tools like worksheets or lists
of questions to use when discussing options with a health
professional [30].Strengths and limitations
Because we recruited both English- and French-speaking
participants, and both clinicians and patients, we were
able to gather a large array of points of views reflecting
some of the future users of Decision Boxes. We recruited
a diversity of male patients, including two men who had
been treated for prostate cancer. However, although we
recruited one woman who had an amniocentesis follow-
ing positive screening, we did not interview any woman
who had had a child with trisomy 21.
Some biases may have affected the focus group inter-
view. For example, the researchers’ presence may have
biased responses towards more positive comments. Also,
participants did not receive the documents in their usual
context, and because they had more time to look at the
documents, they may have underlined more problems
than they would normally have been aware of. We tried
to minimize this bias by setting the context at the begin-
ning of the interviews.
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was a strength of this study. Most the uncovered barriers
are widely applicable to many topics because they describe
communication design, rather than content issues, and
so provide a good basis for developing future Decision
Boxes. However, we did uncover some barriers/facilitators
that were specific to topic in the present evaluation.
Developers of new Decision Boxes should then consider
testing with target users, an important step to uncover
possible barriers specific to topic. For the eight remaining
Decision Boxes, we are planning to further explore the
influence of topic on users’ experience of the Decision
Boxes.
Our interview guide and study design were useful
mostly to explore barriers to integrating the information,
because the participants really experienced these steps
when reading the prototypes at the beginning of the
focus groups. Because participants did not meet with
patients after reading the Decision Boxes, the reported
barriers to using this type of information in practice
needs to be confirmed among a sample of clinicians who
had the opportunity to use what they learned from the
Decision Box with their patients. Our interpretation of
participants’ comments led us to modify the prototypes
to address the problems and limitations they perceived.
We need to verify if our interpretation was right, and if
the choices that we made to address the limitations of
the prototypes truly improved the Decision boxes and
did not generate new problems.
Conclusions
We identified factors influencing the communication
design of Decision Boxes that act when accessing them,
when integrating the information presented within, and
when using them in clinical practice. These factors will
guide the development of the eight remaining Decision
Boxes covering the other topics selected at the beginning
of this project. In the next phase of this program, we will
evaluate users’ perceptions of the Decision boxes that are
to be developed following our interpretation to confirm
that our modifications truly addressed the identified pro-
blems and did not generate new problems. We plan to
use a mixed approach to collect users’ perceptions of the
modified Decision boxes, using the questionnaire tested
in this study and focus groups. In a longer term, we plan
to evaluate the effect of Decision Boxes on the integra-
tion of evidence-based and SDM principles in clinical
practice. We hypothesize that the implementation of
Decision Boxes in clinical practice will prepare the physi-
cians to better communicate the benefits and harms of
the available options to their patients. Better communica-
tion will allow patients to become more involved in deci-
sions concerning their health, and in turn lead to a more
judicious use of current best evidence.Additional file
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